Project Duration: 2015
Donor: Global Alliance for Livestock Veterinary Medicines (GALVmed)
Contacts for ATPS: Dr. Nicholas Ozor, Executive Director, ATPS
Program Coordinator: Dr. Nicholas Ozor
Project Value: US$ 38,610
Village poultry production has been known to be a familiar and successful income-generating activity for poor rural women in Ghana and Nigeria. However, it is unfortunate to note that the free-range scavenging village poultry is not rated highly in the mainstream of national economies because of the lack of measurable indicators. Outputs in terms of weight gain and the number of eggs per hen per year are very low with relatively high mortality rates (especially in young chicks). Several reasons for this high mortality and low productivity have been suggested, including suboptimal management, malnutrition, predation, and most importantly the myriads of diseases to which the village poultry is susceptible to. Among the diseases constraining both commercial and village/poultry production and one that is endemic in most part of the tropical region is Newcastle disease. The project seeks to conduct a market scoping study in order to gain clear understanding of the vaccine production and marketing landscape specifically in Nigeria and Ghana, the registration status of available ND vaccines and to determine the potential socio-economic impact of ND vaccination on the livelihood of village poultry producers especially women.
Project Purpose and Objectives
The overall purpose of the study is to understand the Newcastle disease epidemiology, socio-economic impact on the livelihood of small scale village poultry producers, especially women and to determine availability, registration status and large scale sustainable distribution mechanisms of ND vaccines including, thermostable I2, Itanew etc., in Nigeria and Ghana.
Specifically, the study is meant to:
The outputs expected from this market scoping study will include: